CHUM
Liver cancer treatment: Utilizing magnetic field-guided microrobots
12.04.2024
A new medical technique utilizing magnet-guided microrobots for treating liver tumors has been developed by a Canadian research team, offering a potential new approach in oncology.
Viscient Biosciences
Revolutionizing liver disease research with 3D bioprinted model
07.02.2024
Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH), is a liver disease characterized by inflammation and scarring, reaching epidemic proportions with an estimated 1.5 percent to 6.5 percent of U.S. adults affected.
Colourbox
Ultrasound: special probes improve imaging in obese patients
24.10.2023
A new study conducted at the University of Leipzig Medical Center and supported by the Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG) shows that obesity affects the quality of ultrasound scans of the liver and kidneys.
Dt. Leberstiftung
Predicting severe liver disease with simple tools
08.09.2023
A European consortium with the participation of the MHH is developing a new tool to determine the individual risk of liver fibrosis and liver cancer.
Natabuena
Functional imaging: intestinal and liver diseases mutually influence each other
06.07.2023
The research groups of Prof. Trautwein (University Hospital RWTH Aachen) and Prof. Hengstler (Leibniz Research Centre for Working Environment and Human Factors in Dortmund) have made a surprising discovery about the interaction of the liver and the intestine.
Karin Kaiser / MHH
With ultrasound against liver cancer
24.05.2023
The Hannover Medical School (MHH) enters into a clinic partnership with Uzbekistan and supports with a training program for sonography diagnostics of hepatocellular carcinoma (HCC).
Thor Balkhed/Linköping University
Adverse muscle composition associated with increased mortality risk in people with fatty liver disease
01.03.2023
Obesity and a sedentary lifestyle contribute to an increasing number of people developing fatty liver disease. There is a need for early detection of individuals at risk of developing sequelae.
The University of Hong Kong
'Reduce and Remove': new treatment strategy for locally advanced liver cancer
19.01.2023
A pioneering phase II clinical study on tri-modality therapy (START-FIT), conducted by the Department of Surgery and Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has found that nearly 50% of patients with inoperable locally advanced liver cancer, can be cured through such an innovative approach.
LipiTUM
MoSBi: Algorithm identifies disease subtypes
01.08.2022
Doctors have always used symptoms, imaging, and laboratory data to define and diagnose diseases, but at times it is simply not enough: while patients may have the same illness, it may exhibit different changes at the molecular level. A team from the Technical University of Munich has developed the so-called MoSBi algorithm and makes it available to researchers to identify molecular differences.
Charité – Universitätsmedizin Berlin
Machine Perfusion: Increasing the Safety of Marginal Organ Transplants
03.01.2022
The shortage of donor organs is a major global issue. An aging population, a reluctance towards organ donation, and logistical challenges related to organ shipping play an important role in this setting. Machine perfusion can be a way to expand and preserve the donor pool for eligible transplant recipients.
Christian Morawe/Universitätsmedizin Magdeburg
Histotripsy: fighting tumors with microbubbles
08.09.2021
Focused ultrasound waves create microbubbles in a fluid – a phenomenon called cavitation. In a current study, this process is used to destroy liver tumors and metastases.